NYSEArca - Delayed Quote USD

T. Rowe Price Total Return ETF (TOTR)

40.46 -0.05 (-0.11%)
At close: October 28 at 4:00 PM EDT
Loading Chart for TOTR
DELL
  • Previous Close 40.51
  • Open 40.49
  • Bid 36.54 x 1200
  • Ask 50.56 x 800
  • Day's Range 40.40 - 40.55
  • 52 Week Range 38.20 - 42.05
  • Volume 3,775
  • Avg. Volume 5,869
  • Net Assets 128.76M
  • NAV 40.65
  • PE Ratio (TTM) 1.84
  • Yield 5.11%
  • YTD Daily Total Return 2.93%
  • Beta (5Y Monthly) 1.00
  • Expense Ratio (net) 0.32%

The fund invests in a diversified portfolio of bonds and other debt instruments. The fund’s investments typically include, but are not limited to, debt instruments issued by the U.S. government and its agencies, corporate bonds, bank loans, and various types of mortgage-backed and asset-backed securities. The fund may purchase or sell mortgage-backed securities on a delayed delivery or forward commitment basis through the “to-be-announced” (TBA) market.

T. Rowe Price

Fund Family

Intermediate Core-Plus Bond

Fund Category

128.76M

Net Assets

2021-09-28

Inception Date

Performance Overview: TOTR

View More

Trailing returns as of 10/25/2024. Category is Intermediate Core-Plus Bond.

YTD Return

TOTR
2.93%
Category
5.27%
 

1-Year Return

TOTR
12.30%
Category
12.41%
 

3-Year Return

TOTR
2.58%
Category
1.16%
 

People Also Watch

Holdings: TOTR

View More

Sector Weightings

SectorTOTR
Technology   15.11%
Utilities   10.14%
Healthcare   1.77%
Industrials   0.98%
Energy   0.13%
Real Estate   0.06%

Related ETF News

View More

Research Reports: TOTR

View More
  • Merck's Wide Moat Is Supported by Leading Oncology Drug Keytruda and a Growing Pipeline

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

    Rating
    Price Target
     
  • Daily – Vickers Top Insider Picks for 08/05/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Coca-Cola Earnings: Consumer-Led Innovation and Digital Engagement Fuel Revenue Expansion

    Founded in 1886, Atlanta-headquartered Coca-Cola is the world’s largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.

    Rating
    Price Target
     
  • Daily – Vickers Top Insider Picks for 07/15/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

Related Tickers